1. Home
  2. RBKB vs ANIK Comparison

RBKB vs ANIK Comparison

Compare RBKB & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RBKB

Rhinebeck Bancorp Inc.

HOLD

Current Price

$12.48

Market Cap

185.9M

Sector

Finance

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$21.23

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBKB
ANIK
Founded
1860
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.9M
200.9M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
RBKB
ANIK
Price
$12.48
$21.23
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
203.3K
88.4K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
215.00
80.16
EPS
0.20
N/A
Revenue
$2,984,000.00
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
$62.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$8.22
52 Week High
$17.99
$22.88

Technical Indicators

Market Signals
Indicator
RBKB
ANIK
Relative Strength Index (RSI) 31.68 71.05
Support Level $11.63 $14.13
Resistance Level $12.63 N/A
Average True Range (ATR) 0.33 1.23
MACD 0.05 0.44
Stochastic Oscillator 73.58 79.76

Price Performance

Historical Comparison
RBKB
ANIK

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: